Dépôt numérique
RECHERCHER

HSP60 controls mitochondrial ATP generation for optimal virus-specific IL-21-producing CD4 and cytotoxic CD8 memory T cell responses

Téléchargements

Téléchargements par mois depuis la dernière année

Ghahari, Nazanin; Shegefti, Saina; Alaei, Mahsa; Amara, Amine; Telittchenko, Roman; Isnard, Stephane; Routy, Jean-Pierre; Olagnier, David et van Grevenynghe, Julien ORCID logoORCID: https://orcid.org/0000-0002-2952-4081 (2024). HSP60 controls mitochondrial ATP generation for optimal virus-specific IL-21-producing CD4 and cytotoxic CD8 memory T cell responses Communications Biology , vol. 7 , nº 1688. pp. 1-19. DOI: 10.1038/s42003-024-07326-8.

[thumbnail of HSP60 controls mitochondrial ATP.pdf]
Prévisualisation
PDF - Version publiée
Disponible sous licence Creative Commons Attribution Non-commercial No Derivatives.

Télécharger (5MB) | Prévisualisation

Résumé


We have shown that virus-specific CD4 and CD8 memory T cells (TM) induce autophagy after T cell receptor (TCR) engagement to provide free glutamine and fatty acids, including in people living with HIV-1 (PLWH). These nutrients fuel mitochondrial ATP generation through glutaminolysis and fatty acid oxidation (FAO) pathways, to fulfill the bioenergetic demands for optimal IL-21 and cytotoxic molecule production in CD4 and CD8 cells, respectively. Here, we expand our knowledge on how the metabolic events that occur in the mitochondria of virus-specific TM down-stream of the autophagy are regulated. We show that HSP60 chaperone positively regulates the protein levels for multiple glutaminolysis- and FAO-related enzymes, thereby actively fueling the levels of cellular alpha-ketoglutarate (αKG) and related mitochondrial ATP-dependent antiviral T cell immunity in both CD4 and CD8 TM. Finally, we provide a way to rescue defective ATP generation in mitochondria and dependent effector functions in virus-specific TM including anti-HIV-1 protective responses, when HSP60 expression is impaired after TCR engagement in patients, in the form of dimethyl 2-oxoglutarate (DMKG) supplementation.

Type de document: Article
Mots-clés libres: -
Centre: Centre INRS-Institut Armand Frappier
Date de dépôt: 06 janv. 2025 06:02
Dernière modification: 06 janv. 2025 06:02
URI: https://espace.inrs.ca/id/eprint/16244

Gestion Actions (Identification requise)

Modifier la notice Modifier la notice